India is currently in need of scaling up the process of introduction of new chemical entities which require heavy investments. The industry specialists opine that introduction of Market Based Pricing (MBP) will provide enough support to the Indian pharma industry operators. The Union government’s decision on National Pharmaceutical Pricing Policy (NPPP) for adoption of the MBP is long awaited.India’s growing potential in development of drugs for almost every therapeutic area like its western counterpart, can be supported only by adoption of the MBP.
Presently Indian drug prices are low that is harmful for the growth and stability of the Indian pharma companies and hence is in need of a pricing strategy that would boost the industry’s growth process.
Source: Pharmabiz